Invesco Pharmaceuticals ETF
PJP
122 hedge funds and large institutions have $154M invested in Invesco Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 13 closing their positions.
1,525% more capital inflows, than outflows
Capital inflows: $93.8M | Capital outflows: $5.78M
131% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 13
57% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 21
26.9% more ownership
Funds ownership: 22.56% → 49.47% (+27%)
13% more funds holding
Funds holding: 108 → 122 (+14)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $259K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$24.4M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$23.4M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$5.51M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.45M |
| 5 |
Cavalier Investments
Alpharetta,
Georgia
|
+$4.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIG Financial Advisory Services
Oklahoma City,
Oklahoma
|
-$1.54M |
| 2 |
WBI Investments
Red Bank,
New Jersey
|
-$739K |
| 3 |
Intelligence Driven Advisers
Carlsbad,
California
|
-$565K |
| 4 |
HBW Advisory Services
Simi Valley,
California
|
-$533K |
| 5 |
Grimes & Company
Westborough,
Massachusetts
|
-$502K |
PJP Hedge Fund Activity: Q1 2026 in Review
122 of the 8,241 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2026, worth a combined $154M — up 118% from $71M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new PJP positions and 13 closed out — a net gain of 17 holders — while 33 added to existing stakes and 21 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $24.4M. The largest seller was FIG Financial Advisory Services, exiting entirely with an estimated $1.54M sold.
- 122 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2026, up from 108 in Q4 2025.
- Funds reported $154M of Invesco Pharmaceuticals ETF stock for Q1 2026, up 118% quarter-over-quarter.
- 30 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2026 and 13 closed out, a net change of +17 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2026 was Morgan Stanley, an estimated $24.4M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2026 was FIG Financial Advisory Services, an estimated $1.54M sold.
Based on aggregated 13F filings for Q1 2026.